Patents by Inventor Boris Meandzija

Boris Meandzija has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Smoking cessation treatments using naltrexone and related compounds
    Patent number: 6541478
    Abstract: Nicotine dependency is treated by administration of an opioid antagonist. In some embodiments, rapid or ultra rapid detoxification techniques include using a combination of an effective amount of an opioid antagonist such as nalmefene, naloxone or naltrexone or a mixture of any one of these, and either clonidine or related compounds either while awake, or while under sedation or anesthesia, followed by continued administration of an effective amount of an opioid antagonist with or without agents that enhance nicotine dependency treatment.
    Type: Grant
    Filed: September 16, 1999
    Date of Patent: April 1, 2003
    Assignee: Yale University
    Inventors: Stephanie O'Malley, Boris Meandzija, Suchitra Krishnan-Sarin
  • Smoking cessation treatments using naltrexone and related compounds
    Patent number: 6004970
    Abstract: Nicotine dependency is treated by administration of an opioid antagonist. In some embodiments, rapid or ultra rapid detoxification techniques include using a combination of an effective amount of an opioid antagonist such as nalmefene, naloxone or naltrexone or a mixture of any one of these, and either clonidine or related compounds either while awake, or while under sedation or anesthesia, followed by continued administration of an effective amount of an opioid antagonist with or without agents that enhance nicotine dependency treatment.
    Type: Grant
    Filed: November 12, 1997
    Date of Patent: December 21, 1999
    Assignee: Yale University
    Inventors: Stephanie O'Malley, Boris Meandzija, Suchitra Krishnan-Sarin, Patrick G. O'Connor